King Charles’ doctor has warned that using Ozempic for weight loss discourages personal responsibility in favor of “medicalizing everything” and puts a huge burden on the NHS.
Dr Michael Dixon, an NHS GP who became head of the Royal Household when Prince Charles became king, said he was dismayed by the growing demand for weight loss jabs, saying: ‘The more we go down this Ozempic route, the more likely we are to I believe there will be more claims to make.” , “It’s not my fault, give me a shot, give me a pill.”
Instead of prescription drugs, Dr Dixon, 72, advocates for bringing care back into the community and taking a more holistic approach to problems such as obesity.
He also believes it is “insane” that one in six adults in the UK is taking antidepressants, and blames this figure in part on the pressure GPs are under. he is thinking.
“If each appointment is only five or 10 minutes, it’s much easier for me to give them Prozac than to start talking about the stresses of life and work and everything else.”
Dr Dixon, who is sometimes ridiculed for his support of alternative medicine, told the Times:
“The more we depend on experts and Ozempic and everything else, the less independent we become and the less sustainable our health services become.”
King Charles’ personal doctor Dr Michael Dixon (pictured with the king) warned that using Ozempic for weight loss would place a huge burden on the NHS.
Dr Dixon, 72, advocates for bringing medicine back into the community instead of prescription drugs and taking a more holistic approach to problems such as obesity (stock image)
Dr Dixon’s warning comes as it emerges that the number of people hospitalized due to side effects of weight loss drugs is more than four times higher than previously thought.
The medicines regulator said last month that 68 people had been hospitalized in the UK in connection with “miracle” weight loss drugs such as Ozempic, which is used to treat obesity and diabetes.
But this figure is now much higher at 274, with the number of side effects associated with the drug reaching a staggering 14,996, according to the Medicines and Healthcare products Regulatory Agency (MHRA), out of 7,228 reported cases. It turned out to be more than double. last month.
The surge in side effects and hospitalizations is mainly related to gastrointestinal side effects such as nausea, vomiting, constipation and diarrhea, the watchdog said.
